Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Monoclonal antibodies show promise for HIV-positive people with limited treatment options

News
22 February 2017
New & experimental HIV treatments

New nano approach could cut dose of leading HIV treatment in half

Editor's pick
University of Liverpool press release
21 February 2017
Pharmaceutical industry

Merck's lead HIV play hits the mark in first phase 3 challenge

Editor's pick
FierceBiotech
19 February 2017
New & experimental HIV treatments

New NNRTI doravirine shows good efficacy in phase 3 study

News
19 February 2017
Treatment simplification strategies

Dual antiretroviral regimen maintains durable HIV suppression after switch

News
15 February 2017
New & experimental HIV treatments

Integrase inhibitor bictegravir matches dolutegravir for first-line HIV treatment

News
14 February 2017
New & experimental HIV treatments

URMC drug extends effectiveness of HIV therapy

Editor's pick
EurekAlert (press release)
31 January 2017
New & experimental HIV treatments

SA can save billions with new HIV drug combination

Editor's pick
Health24
17 January 2017
Changing treatment

GlaxoSmithKline’s New Drug Challenges HIV Treatment Orthodoxy

Editor's pick
Wall Street Journal
20 December 2016
New & experimental HIV treatments

Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen

Editor's pick
Janssen press release
20 December 2016
New & experimental HIV treatments

Charlie Sheen Achieves Undetectable Viral Load With Weekly Injectable HIV Treatment

Editor's pick
The Body
8 December 2016
HIV treatment

Top 10 HIV Clinical Developments of 2016

Editor's pick
The Body Pro
2 December 2016
New & experimental HIV treatments

China to approve 1st long-acting injection to treat HIV/AIDS

Editor's pick
Global Times
25 November 2016
New & experimental HIV treatments

ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen

Editor's pick
ViiV press release
21 November 2016
PrEP science

The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study

News
11 November 2016
Pharmaceutical industry

‘Hard’ Brexit would delay access to new drugs, warns report

Editor's pick
Pharma Times
9 November 2016
New & experimental HIV treatments

Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV

News
4 November 2016
Treatment simplification strategies

Four days on, three days off HIV treatment controls viral load in French pilot study

News
3 November 2016
Pharmaceutical industry

GSK discontinues development of maturation inhibitor BMS-986173

Editor's pick
HIV i-Base
31 October 2016
Treatment simplification strategies

Darunavir/ritonavir & lamivudine matches triple-drug therapy

News
31 October 2016
New & experimental HIV treatments

New long-acting fusion inhibitor albuvirtide plus boosted protease inibitor matches standard triple-drug therapy

News
28 October 2016
PrEP

Two Thirds of Oral PrEP-Using MSM Would Switch to Long-Term Shots

Editor's pick
NATAP
26 October 2016
PrEP

More Surprises From ÉCLAIR: Cabotegravir's 'Long Tail'

Editor's pick
Medscape (requires free registration)
26 October 2016
New & experimental HIV treatments

New nanomedicine approach aims to improve HIV drug therapies

Editor's pick
Science Daily
24 October 2016